| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYHS2302006 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(3) | Generic Drug | 2023-07-27 | view | ||||
| CYHS2402395 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(4) | Generic Drug | 2024-07-30 | Jiangxi Kerui Pharmaceutical Co Ltd | view | |||
| CYHS2402608 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(4) | Generic Drug | 2024-08-13 | Hainan Star Pharmaceutical Co Ltd | view | |||
| CYHS2403738 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(4) | Generic Drug | 2024-11-02 | view | ||||
| CYHS2403739 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(4) | Generic Drug | 2024-11-02 | view | ||||
| JTH2100038 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs | Disposable Import Drug Application | 2021-02-05 | Vifor SA, Zweigniederlassung Medichemie Ettingen | Corden Pharma Fribourg AG Zweigniederlassung Ettingen | Certificate Issued | 2021-03-02 | view |
| JXHL2100023 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2021-01-23 | 深圳市康哲生物科技有限公司 | Shenzhen Kangzhe Biotechnology Co Ltd | In Review | 2021-01-22 | view |
| JXHS2200062 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2022-07-22 | view | ||||
| JXHS2400001 | 熊去氧胆酸口服混悬液 | ursodeoxycholic acid | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2024-01-04 | view |